Objectives-To investigate the diagnostic performance of a 2-dimensional shear wave elastographic technique (Virtual Touch tissue imaging and quantification [VTIQ]; Siemens Medical Solutions, Mountain View, CA) for predicting thyroid malignancy.
T hyroid nodules have been detected at an increasing rate, partially because of the widespread use of high-frequency conventional sonography, although only 5% to 15% are malignant. 1 Ultrasound-guided fine-needle aspiration (FNA) is one of the most widely used modalities for evaluating thyroid nodules. 2 Conventional sonographic features, such as intranodular microcalcification, an irregular margin, a taller-than-wide shape and marked hypoechogenicity, have been reported to be associated with thyroid malignancy. 3 However, there are overlapping sonographic features between benign and malignant thyroid nodules, and the inter-reader agreement is variable. 4, 5 On the other hand, the large number of thyroid nodules poses a great challenge to medical resources if all nodules undergo FNA without efficient preselection. In addition, nondiagnostic cytologic results after FNA ranged from 6.5% to 36.4%, which lead to a considerable amount of repeated biopsy or diagnostic surgery, although most nodules are benign. 6 Therefore, how to objectively assess the nature of thyroid nodules in a noninvasive way should be prioritized.
Ultrasound elastography, including strain elastography and shear wave elastography (SWE), has gained increasing attention in recent years and provides additional information on tissue stiffness over conventional sonography qualitatively and quantitatively. 7 A recent prospective multicenter study confirmed that combining strain elastography and conventional sonography markedly increased the sensitivity for thyroid carcinoma detection. 8 However, strain elastography has been proven to be operator dependent, to be subject to external compression, and to have questionable reproducibility. 9 On the other hand, SWE objectively monitors shear wave propagation away from the acoustic radiation force push location in the target area and then the Young modulus is displayed as in kilopascals or denoted as shear wave speed (SWS) in meters per second on the ultrasound machine screen. [10] [11] [12] Shear wave elastography is further divided into point SWE and 2-dimensional (2D) quantitative SWE. The diagnostic performance of point SWE has been proven to be better than other independent conventional sonographic features in evaluating thyroid malignancy. 9 As a kind of 2D quantitative SWE, Virtual Touch tissue imaging and quantification (VTIQ; Siemens Medical Solutions, Mountain View, CA) has been introduced in clinical fields for assessing lesions in the breast, salivary glands, and pediatric liver. [13] [14] [15] With VTIQ, a longitudinal acoustic radiation force impulse is generated from the transducer. This technique then measures the speed of the shear wave, which propagates in a perpendicular direction by a detection pulse. The image is acquired by translating the pushing the focus to cover up to 256 acquisition lines within 700 milliseconds. For each image, SWS is calculated at a number of locations around the pushing focus. 16 Compared with the previous point SWE technique, 2D SWE might provide more precise stiffness information within thyroid nodules because of its 2D visualization of the SWS distribution in various colors and a smaller shear wave region of interest (ROI; ie, 1.5 3 1.5 mm).
To our knowledge, few studies have been conducted for exploring the usefulness of VTIQ for diagnosing thyroid nodules. 17 Hence the aim of this study was to explore the usefulness and reproducibility of VTIQ in predicting thyroid malignancy.
Materials and Methods

Patients
The study was approved by the Ethics Committee of the university hospital, and all patients enrolled in this study provided informed consent to include the data for analysis. From June 2014 to December 2014, a total of 1500 consecutive patients with a diagnosis of thyroid nodules underwent conventional sonographic and VTIQ examinations before FNA or surgery. The inclusion criteria were as follows: (1) nodule size between 5 and 35 mm, since nodules smaller than 5 mm have no importance in clinical practice, and the sampling box for VTIQ makes it difficult to include nodules larger than 35 mm completely; (2) nodules with solid or mixed components (cystic portion <75%); and (3) nodule depth of less than 50 mm from the skin, since it is difficult to detect the shear wave at such a depth. For multiple nodules coexisting in the same patient, the most suspicious nodules (ie, with the most suspicious features on conventional sonography, such as a taller-than-wide shape, hypoechogenicity, microcalcification, a poorly defined margin, and intranodular vascularity) were selected; otherwise, the largest one was selected. 2 In general, only 1 nodule was selected for FNA in each patient. In cases with suspicious nodules in both thyroid lobes, 2 or 3 nodules were selected for FNA. No patients received FNA for more than 3 nodules. Finally, 982 patients with 1050 nodules were enrolled. The exclusion criteria were defined as follows: (1) a history of invasive procedures, such as surgery or FNA, before enrollment (15 patients with 17 nodules); and (2) no histopathologic results or a follow-up period of less than 6 months for those with initially benign cytologic results on FNA (677 patients with 731 nodules). Ultimately, 290 patients with 302 thyroid nodules were included in the study (Figure 1 ). One nodule was selected for evaluation in 279 patients, 2 in 10 patients, and 3 in 1 patient.
Conventional Sonographic Examinations
Conventional thyroid sonographic examinations were performed with an Acuson S3000 ultrasound scanner (Siemens Medical Solutions) equipped with an 18L6 linear array transducer (frequency range, 7-17 MHz) and a 9L4 linear array transducer (frequency range, 4-9 MHz). The patient was asked to lie on the bed in a supine position with slight dorsal flexion of the head. In general, the 18L6 transducer was first used, since it provides a better spatial resolution; thus, it is helpful for observing the subtle sonographic features in the nodule. However, for large or deeply located nodules, the 9L4 transducer was also used, with an aim to obtain more acoustic penetration. Conventional sonograms were obtained by carefully scanning the thyroid and adjacent tissues transversely and longitudinally. The ultrasound machine settings were optimized to obtain good-quality sonograms images, and then the images were recorded in the internal hard disk for further offline analysis. The nodule size was defined by the maximal diameter on sonography. Afterward, 2 other investigators who did not participate in image acquisition and were blinded to patients' medical information reviewed all of the sonograms images independently. Disagreements were solved by consensus.
The sonographic features included nodule echogenicity, shape, margin, internal component, and calcification. Based on the internal solid component, the echogenicity was classified as marked hypoechogenicity (less echogenicity compared with surrounding strap muscle or thyroid parenchyma), isoechogenicity (echogenicity equal to surrounding thyroid parenchyma), and hyperechogenicity (more echogenicity compared with surrounding thyroid parenchyma). The shape was categorized as taller than wide (larger in its anteroposterior dimension than in its transverse dimension) or wider than tall. The margin was classified as poorly defined, microlobulated, or regular. The internal component was classified as solid, more than half solid, or less than half solid. Microcalcification was defined if calcification was equal to or less than 1 mm in diameter or tiny spot foci with or without acoustic shadows were detected. Macrocalcification was defined if its diameter was larger than 1 mm. If both microcalcification and macrocalcification were present in the same nodule, it was referred to as having microcalcification.
Virtual Touch Tissue Imaging and Quantification Examinations
The VTIQ examinations were then performed with the 9L4 transducer, since the 18L6 transducer does not have the VTIQ function. With the transducer kept perpendicular to the skin, the VTIQ mode was implemented. All images were obtained when patients were holding their breath for 3 to 5 seconds, since breathing might have hampered the proper shear wave signal propagation in the nodule. First, the investigator selected the target nodule with the linear transducer at its largest dimension in the B-mode, and then the shear wave quality map was obtained. The pulse of the carotid artery was also taken into account, and all nodules were examined in the longitudinal direction. The shear wave quality map is a color-coded interpretation of SWS propagation in the target area, with green representing high quality, yellow moderate quality, and red low quality. Second, the imaging mode was shifted to the shear wave velocity (SWV) mode. Because the speed of the shear waves propagating through the tissue increases along with the stiffness of the tissue, a color quantitative 2D SWV map in the target area reveals information on the tissue stiffness in the ROI. The SWS in the SWV map ranges from high (red), intermediate (yellow to green), to low (blue) so that the investigator is able to determine the ROI placement according to the various colors for obtaining the highest or lowest SWS. The quantitative assessment of the tissue stiffness is denoted by the SWS up to 10 m/s. In general, 7 ROIs were placed according to previous literature. 9, 18 If the SWV map showed a homogeneous color scale image, the placement of ROIs was random. Otherwise, the ROIs were placed according to the color scale gradient of the SWV map, from highest to lowest SWS area, including 1 stiffest area (ie, red area) and 1 softest area (ie, blue area). During this procedure, cystic components, visible calcifications, on conventional sonography, and components corresponding to low quality on in the shear wave quality mode in the target nodule were avoided as far as possible. Finally, all data were stored in the internal hard disk for future analysis. The maximum SWS (SWS max ) and minimum SWS (SWS min ) corresponded to the highest and lowest SWS values acquired in the elastogram. The average value of 7 SWSs was calculated as the mean SWS (SWS mean ).
Reference Standard
Ultrasound-guided FNA was performed with a 23-gauge percutaneous transhepatic cholangiography needle attached to a 5-mL disposable plastic syringe. For heterogeneous nodules, the solid portions in the nodules were selected as the biopsy sites, and usually 5 to 10 back-and-forth maneuvers were performed in various directions within the solid portions. Each lesion was aspirated at least 3 times. Materials obtained from aspiration biopsy were expelled onto glass slides and smeared. All smears were placed immediately in 95% alcohol for fixation and were then submitted for hematoxylin-eosin staining. Cytopathologists were not on site during the biopsy. The FNA results were interpreted by a single experienced cytologist according to the principles of the Bethesda system: nondiagnostic, benign, atypia of undetermined significance, follicular lesion of undetermined significance, follicular neoplasm, suspicious for a follicular neoplasm, suspicious for malignancy, and malignant. 17 The term "benign FNA result" applies to the following: (1) an adequately cellular specimen composed of varying proportions of colloid and benign follicular cells arranged as macrofollicles and macrofollicle fragments; (2) consistent with Hashimoto thyroiditis in the proper clinical context; and (3) consistent with subacute thyroiditis. The term "malignant FNA result" is defined as increased cellularity, tumor cells arranged in sheets, papillary cell groups, and typical nuclear abnormalities, which include intranuclear holes and grooves (intranuclear cytoplasmic pseudoinclusions). 19 The duration of imaging follow-up with sonography for the nodules with initially benign FNA findings was 6 to 13 months, and nodule stability (no more than a 50% change in volume or <20% increase in at least 2 nodule dimensions in solid nodules or in the solid portion of mixed cystic-solid nodules) was confirmed according to the American Thyroid Association guidelines. 2 The indications for surgical intervention were as follows: nondiagnostic (n 5 23), atypia of undetermined significance (n 5 25), follicular neoplasm or suspicious for a follicular neoplasm (n 5 3), suspicious for malignancy (n 5 15), and malignant (n 5 19) on FNA results, highly suspicious on sonography (n 5 20), and compressive symptoms or discomfort caused by large nodules or associated large nodules (n 5 30).
Intraoperator and Interoperator Reproducibility of VTIQ Elastography
Thirty consecutive patients with 30 thyroid nodules were enrolled in the study for evaluating intraoperator reproducibility of VTIQ elastography by a single experienced radiologist with more than 2 years of experience in elastography. The examination was performed with a 1-day interval before surgery or FNA. In addition, to test whether experience in elastography affected the VTIQ results, we performed an interoperator test in which both a beginner (with 3 months of experience in elastography) and the experienced investigator participated. The beginner was trained under the experienced investigator's instruction to perform VTIQ on 20 patients who were not included in the study design. Then another consecutive 30 patients with 30 nodules were collected for the assessment of interoperator reproducibility. The operators were blinded to each other's measurements while performing VTIQ on the same day (with a 10-to 30-minute interval between measurements).
Statistical Analyses
Statistical analyses were performed with SPSS version 19.0 software (IBM Corporation, Armonk, NY). The reference standards were cytologic examinations in combination with follow-up results or histopathologic results for benign nodules and histopathologic results for malignant nodules. Descriptive statistics were applied to all collected variables, which were expressed as frequency tables for categorical data and means 6 standard deviations for continuous data. Continuous variables were compared by an unpaired Student t test and categorical variables by a v 2 test. If there were cells with fewer than 5 observations, the Fisher exact probability test was used. A receiver operating characteristic curve was plotted to obtain the area under the curve (AUC), optimal SWS cut off value, sensitivity, specificity, positive predictive value, negative predictive value, and accuracy in all nodules as well as in nodules categorized into different sizes. The method of DeLong et al 20 was followed to compare AUCs among the 3 SWS indices (SWS max , SWS min , and SWS mean ) in all nodules and subgroup nodules with different sizes. For multiple pair-wise comparisons of receiver operating characteristic curves, a P value of less than the Bonferroni-corrected significance value was applied. Otherwise, 2-tailed P < .05 was considered statistically significant. 
Results
Final Diagnosis
The 290 patients included 88 men and 202 women with a mean age 6 SD of 49.80 6 12.34 years (range, 17-76 years). Two hundred thirty-seven nodules were benign, and 65 nodules were malignant. Thyroid malignancy consisted of papillary thyroid carcinoma (n 5 32; Figure  2 ), micropapillary thyroid carcinoma (n 5 27), follicular carcinoma (n 5 2), medullary carcinoma (n 5 3), and undifferentiated carcinoma (n 5 1). All were confirmed by pathologic examination after surgery. There were 167 cytopathologically confirmed benign nodules and 70 benign nodules confirmed by pathologic specimens, including Hashimoto nodules (n 5 13), nodular goiters (n 5 42), and adenoma (n 5 15). There were no falsenegative FNA results. No major complications of FNA were encountered. Among the benign nodules confirmed by surgery, 2 were diagnosed as suspicious for malignancy on FNA. The mean size of malignant nodules was comparable to that of benign ones. There were no significant differences in age and sex between patients with malignant nodules and those without (Table 1) .
Conventional Sonography
On conventional sonography, a solid component, a taller-than-wide shape, microcalcification, a poorly defined margin, and hypoechogenicity were all significantly predictive of thyroid malignancy (all P < .05; Table 2 ). With the highest sensitivity, the solid component achieved low specificity for diagnosing thyroid malignancy. On the other hand, a taller-than-wide shape was present in most malignant nodules, with low sensitivity and reasonable specificity (Table 3) .
Virtual Touch Tissue Imaging and Quantification and its Diagnostic Performance
The mean SWS max , SWS min , and SWS mean values of all nodules were 3.15 6 1.15 (range, 1.78-9.60), 2.33 6 0.69 (range, 0.63-5.49), and 2.71 6 0.86 (range, 1.24-7.35) m/s, respectively, all of which were higher in thyroid malignancies than in benign nodules (all P < .001; Figures 2 and 3) . For discrimination between malignant and benign nodules, all SWS indices showed better performance than conventional sonographic features for predicting thyroid malignancy (all P < .05). The highest AUC attainable was for SWS mean . The cutoff value for SWS mean was 2.60 m/s. An SWS mean value of less than 2.0 m/s was not encountered in any thyroid malignancy. The AUCs of SWS max and SWS min were slightly lower than that of SWS mean , but no statistically significant differences were found among them (both P > .05). The NPVs of all 3 SWS indices were higher than 90% (Table  3 ). There were 9 false-negative cases concerning SWS mean for diagnosing thyroid nodules, which included papillary thyroid carcinoma (n 5 6), micropapillary thyroid carcinoma (n 5 2), and follicular carcinoma (n 5 1).
When dividing the nodules into 2 separate groups with different sizes, the diagnostic performance (AUC) of all 3 SWS indices in nodules larger than 10 mm was better than in nodules of 10 mm or smaller (all P < .05). The highest AUC was obtained by applying a cutoff SWS mean value of 2.59 m/s for diagnosing thyroid nodules larger than 10 mm. If a cutoff SWS mean value of 2.10 m/s were applied in clinical practice for screening thyroid nodules larger than 10 mm, sensitivity of 100% and a specificity of 26.8% (33 of 123) would be achieved. The negative predictive value of SWS mean was slightly higher than that of SWS max and SWS min . The corresponding sensitivity, specificity, accuracy, positive predictive value, and negative predictive value in different thyroid nodules sizes are shown in Table 4 . 
Discussion
In this study, a solid component, a taller-than-wide shape, microcalcification, a poorly defined margin, and hypoechogenicity were all significant predictors for thyroid malignancy, which was consistent with previous literature. 22, 23 However, none of them showed balanced SWE in distinguishing thyroid malignancy from benign nodules. 9, 11, 24, 25 However, the fixed ROI box (ie, 5 3 6 mm) for point SWE is an inherent limitation when assessing small nodules, since surrounding thyroid parenchyma might be unavoidably included in the ROI, and the measurement result would be affected. 26 On the other hand, compared with point SWE, the 2D SWE mode is convenient for radiologists to understand the whole SWS distribution in a target nodule according to the coded colors, which facilitates choosing the specific area for shear wave ROI placement. Two-dimension SWE was shown to be powerful in differentiating thyroid malignancy according to previous experience.
12,17,27-31 Liu et al 27 found that the cutoff Young modulus value was 39.3 kPa, with sensitivity of 66.3% and specificity of 84.4%, when placing a 2-mm ROI over the stiffest area with another 2D SWE system (ie, SuperSonic Imagine, Aix-en-Provence, France). However, in their study, the intraobserver and interobserver reproducibility of the technique was not evaluated. With VTIQ, the SWS quality map represent SWS propagation in the nodule, facilitating visualization of the imaging quality of SWE so that ROIs can exclusively be placed in the areas showing good quality, which is absent in the SuperSonic Imagine system.
In this study, the investigator initiated the SWV map and determined the placement of the ROI according to the color-coded SWS distribution in the target nodule. Our results revealed that the AUCs of the 3 SWS indices (0.801-0.820) were comparable to those of other 2D SWE techniques for discriminating thyroid malignancy (AUC range, 0.660-0.852). 27, 29 In this study, the negative predictive values of the 3 SWS indices were all higher than 90% for distinguishing thyroid nodules, which is essential for a screening test (Figure 3 ) and is relevant in clinical practice for management of thyroid nodules. If a nodule's SWS is under the cutoff SWS mean value of 2.60 m/s, unnecessary FNAs might be avoided in approximately 90% of nodules. Furthermore, in this study, an SWS mean of less than 2 m/s was not found in any malignancy (Table 2) ; thus, the negative predictive value of VTIQ could increase to 100% when using an SWS mean of 2m/s as a threshold. Therefore, when an SWS mean of less than 2 m/s is encountered, unnecessary FNAs could be avoided despite other factors. Thus, the VTIQ technique may help clinicians eliminate FNAs for definitely benign nodules.
A malignant nodule of 10 mm or smaller in maximum diameter is called papillary thyroid microcarcinoma. Morphologically, this type of nodule does not show obvious changes but is genetically and biologically heterogeneous. A previous study 27 showed relatively inferior diagnostic performance of 2D SWE on the SuperSonic Imagine system for nodules of 10 mm or smaller, which was similar to the results of point SWE of Zhang et al. 32 However, no studies to date have evaluated the role of VTIQ in diagnosing nodules of 10 mm and smaller. With targeted selection of ROI placement in the SWV map and smaller ROIs, this VTIQ technique also revealed the fact that the pathologic components in nodules of 10 mm or smaller might be different from those larger than 10 mm. The diagnostic inadequacy of VTIQ in nodules of 10 mm or smaller also indicated that a combination of conventional sonographic features and VTIQ would be more powerful than VTIQ alone. In this study, if we combined an SWS mean of greater than 2.58 m/s and microcalcification for predicting thyroid malignancy of 10 mm or smaller, the specificity could be significantly elevated to 81.6% (93 of 114) compared with an SWS mean of greater than 2.58 m/s alone (61.4%; P < .001).
Operator independence is an advantage concerning SWE technology in several body parts, 33, 34 In previous literature, Zhang et al 32 conducted a thyroid point SWE reproducibility test in which the correlation coefficients were 0.904 for intraobserver measurement and 0.864 for interobserver measurement. There is a sparse number of studies exploring the reproducibility of 2D SWE. To our knowledge, our study is the first to confirm excellent intraoperator reproducibility of VTIQ of thyroid nodules. It should be noted that the 2 investigators had the same experience in the interoperator investigation by Zhang et al. 32 In this study, we specifically enrolled a beginner and an experienced investigator to evaluate the interoperator reproducibility. The ICC values of the 3 SWS indices were all higher than 0.80, indicating that VTIQ is a reproducible tool, and elastographic experience does not affect performance of the VTIQ technique.
Our study had several limitations. First, a selection bias might have existed, since we only enrolled the most suspicious and largest nodules. The other thyroid nodules could not be totally ruled out for harboring malignancy. Second, the duration of imaging follow-up for the lesions with benign FNA cytologic findings was relatively short, considering that greater than 1 year of follow-up is generally recommended to avoid a sampling error. Third, this work was a singleinstitution study, which represented thresholds determined from our own population. Therefore, we propose a larger multicenter study of VTIQ for predicting thyroid malignancy in the near future. Fourth, several ultrasound-based thyroid imaging reporting and data systems have been proposed for evaluating the malignancy risk of thyroid nodules instead of the various conventional sonographic features used in this study. Although none of them has been widely accepted in the related guidelines, combined use of these systems and VTIQ might be helpful in diagnosing thyroid nodules, and this idea deserves evaluation in the future. Finally, since all thyroid cancers currently undergo tissue sampling for molecular marker evaluation in some institutions, it would be helpful to combine molecular marker evaluation with elastography and conventional sonography in diagnosing thyroid nodules in future studies.
In conclusion, our results reveal that VTIQ is a useful and reproducible tool for distinguishing between malignant and benign thyroid nodules. The diagnostic utility of VTIQ is better in nodules larger than 10 mm than in nodules of 10 mm or smaller. Unnecessary FNAs might be avoided in benign thyroid nodules with an SWS mean of less than 2 m/s.
